Newbridge Financial Services Group’s BriaCell Therapeutics Corp Warrant BCTXW Stock Holding History

Newbridge Financial Services Group’s Portfolio BCTXW Stock Details BCTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,000	Closed	-$53	–	1191
2025 Q4	$53	Hold	1,000	–	–	﹤0.01%	1160
2025 Q3	$32	Hold	1,000	–	–	﹤0.01%	1272
2025 Q2	$75	Buy	+1,000	New	+$90	﹤0.01%	1288

Newbridge Financial Services Group's BCTXW Position: Q1 2026 in Review

Newbridge Financial Services Group sold out of BriaCell Therapeutics Corp Warrant (BCTXW) in Q1 2026, closing a stake of 1,000 shares — an estimated $53 sold.

Newbridge Financial Services Group first reported a position in BCTXW in Q2 2025 and held it in 3 quarters. The position peaked at $75 in Q2 2025. 0 funds tracked by Wall St. Rank hold BCTXW as of Q1 2026.

Newbridge Financial Services Group reported no remaining BriaCell Therapeutics Corp Warrant position as of Q1 2026 after selling out during the quarter.
Newbridge Financial Services Group sold 1,000 BriaCell Therapeutics Corp Warrant shares in Q1 2026, an estimated $53.
Newbridge Financial Services Group first reported a position in BriaCell Therapeutics Corp Warrant in Q2 2025 and held it in 3 quarters.
Newbridge Financial Services Group's BriaCell Therapeutics Corp Warrant position peaked at $75 in Q2 2025.
0 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.